Skip to content

Study on health effects of ingesting "Ripened Extract Made of Sub-aleurone Layer and Crushed Cell Group Taken out from Brown Rice"

Study on health effects of ingesting "Ripened Extract Made of Sub-aleurone Layer and Crushed Cell Group Taken out from Brown Rice" - Study on health effects of ingesting "Ripened Extract Made of Sub-aleurone Layer and Crushed Cell Group Taken out from Brown Rice"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043778
Enrollment
1500
Registered
2021-03-31
Start date
2021-03-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Ingest &quot
Ripened Extract Made of Sub-aleurone Layer and Crushed Cell Group Taken out from Brown Rice&quot

Sponsors

TOYO RICE CORPORATION
Lead Sponsor
Anti-Aging Medical Research Center,Graduate School of Life and Medical Sciences,Doshisha University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [1]Japanese males and females aged 18-99 years [2]Individuals who are healthy and are not received treatment of disease [3]Individuals whose written informed consent has been obtained [4]Individuals judged appropriate for the study by the principal

Exclusion criteria

Exclusion criteria: [1]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, lung disease,or blood disease [2]Individuals who are sensitive to test products or Individual with fear who causes severe allergy in a food and medical supplies [3]Individuals judged inappropriate for the study by the principal

Design outcomes

Primary

MeasureTime frame
QOL questionnaire survey

Countries

Japan

Contacts

Public ContactNaoki Nishiyama

TOYO RICE CORPORATION Special Mission Sales Department

nishiyama@toyo-rice.jp073-471-3011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026